Healing of Bone/Soft Tissue to Different Abutment Biomaterials and the Impact on Marginal Bone Loss

NCT01961635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-02

No results posted yet for this study

Summary

In patients that require a dental implant, does zirconia compared to titanium, or cad-cam acrylic abutments, provide less inflammation, marginal bone loss or infection during the osseointegration period ?

Conditions

Interventions

DEVICE

dental implants

place implant according fabricant guidelines, 2mm sub-crestally

DEVICE

Zirconia abutments

place zirconia abutment on the day of implant placement

DEVICE

Titanium Abutments

place titanium abutment on the day of implant placement

DEVICE

cad-cam acrylic abutments

place cad-cam acrylic abutment on the day of implant placement

PROCEDURE

Subcrestal

place implant 2mm below crestal bone

DEVICE

platform-switch

abutment platform is narrow than implant diameter

PROCEDURE

one-time one-abutment

place the final abutment on the day of surgery and not remove it

PROCEDURE

Torque 20 n/cm2

the amount of torque applied to the abutment

Sponsors & Collaborators

  • Implantology Institute

    lead OTHER

Principal Investigators

  • João Caramês, Phd · Faculdade de Medicina Dentária de Lisboa

  • André Chen Chen, Msc · Faculdade de Medicina Dentária de Lisboa

  • Elena Cervino, Msc · Implantology Institute

  • Helena Francisco, Phd · Faculdade de Medicina Dentária de Lisboa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-03-23
Completion
2017-03-23

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01961635 on ClinicalTrials.gov